CC
VIR icon

Corton Capital’s Vir Biotechnology VIR Stock Holding History

Corton Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,527
Closed -$114K – 416
2025
Q2 		$114K Buy
+22,527
New +$121K 0.13% 304
2024
Q4 		– Sell
-102,400
Closed -$767K – 660
2024
Q3 		$767K Buy
102,400
+57,987
+131% +$504K 0.37% 13
2024
Q2 		$395K Sell
44,413
-4,058
-8% -$38.9K 0.21% 101
2024
Q1 		$491K Buy
48,471
+4,893
+11% +$49.8K 0.18% 140
2023
Q4 		$438K Buy
+43,578
New +$398K 0.14% 201
2022
Q2 		– Sell
-19,098
Closed -$491K – 523
2022
Q1 		$491K Buy
19,098
+4,062
+27% +$120K 0.21% 121
2021
Q4 		$630K Buy
+15,036
New +$589K 0.28% 69

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return